Exact Mass: 454.1012

Exact Mass Matches: 454.1012

Found 38 metabolites which its exact mass value is equals to given mass value 454.1012, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

   

Tivozanib

N-{2-chloro-4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N-(5-methyl-2,3-dihydro-1,2-oxazol-3-ylidene)carbamimidic acid

C22H19ClN4O5 (454.1044)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EK - Vascular endothelial growth factor receptor (vegfr) tyrosine kinase inhibitors C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C93259 - VEGFR Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163953 - VEGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors

   

1,5-dihydroxy-3-methoxybenzene 1-O-(6?-O-galloyl)-beta-D-glucopyranoside|1,5-dihydroxy-3-methoxybenzene-1-O-(6-O-galloyl)-beta-D-glucopyranoside|1-beta-D-(6-O-galloyl)-glucopyranosyloxy-3-methoxy-5-hydroxybenzene|1-O-beta-D-(6O-galloyl)-glucopyranosyl-3-O-methoxy-5-hydroxybenzene

1,5-dihydroxy-3-methoxybenzene 1-O-(6?-O-galloyl)-beta-D-glucopyranoside|1,5-dihydroxy-3-methoxybenzene-1-O-(6-O-galloyl)-beta-D-glucopyranoside|1-beta-D-(6-O-galloyl)-glucopyranosyloxy-3-methoxy-5-hydroxybenzene|1-O-beta-D-(6O-galloyl)-glucopyranosyl-3-O-methoxy-5-hydroxybenzene

C20H22O12 (454.1111)


   

2,4-dihydroxy-6-methylphenyl 6-O-galloyl-beta-D-glucopyranoside|2,4-dihydroxy-6-methylphenyl beta-D-glucopyranoside 6-(3,4,5-trihydroxybenzoate)|myrsinoside A

2,4-dihydroxy-6-methylphenyl 6-O-galloyl-beta-D-glucopyranoside|2,4-dihydroxy-6-methylphenyl beta-D-glucopyranoside 6-(3,4,5-trihydroxybenzoate)|myrsinoside A

C20H22O12 (454.1111)


   

2-methoxy-4-hydroxyphenol 1-O-beta-(6-O-galloyl)glucopyranoside|2-Methyl,1-O-(6-O-3,4,5-trihydroxybenzoyl-beta-D-glucopyranoside)-1,2,4-Benzenetriol|4-hydroxy-2-methoxyphenol 1-O-beta-D-(6-galloyl)glucoside|4-hydroxy-2-methoxyphenol 1-O-beta-D-(6-O-galloyl)glucoside

2-methoxy-4-hydroxyphenol 1-O-beta-(6-O-galloyl)glucopyranoside|2-Methyl,1-O-(6-O-3,4,5-trihydroxybenzoyl-beta-D-glucopyranoside)-1,2,4-Benzenetriol|4-hydroxy-2-methoxyphenol 1-O-beta-D-(6-galloyl)glucoside|4-hydroxy-2-methoxyphenol 1-O-beta-D-(6-O-galloyl)glucoside

C20H22O12 (454.1111)


   

methoxy-tunicoside

methoxy-tunicoside

C20H22O12 (454.1111)


   

3-O-beta-D-[6-(4-hydroxy-3,5-dimethoxybenzoyl)]glucopyranosyl-gamma-pyranone|6-O-(4-hydroxy-3,5-dimethoxybenzoyl)-erigeroside|pyromeconic acid 3-O-beta-D-glucopyranoside 6-(O-4-hydroxy-3,5-dimethoxybenzoate)|pyromeconic acid 3-O-beta-D-glucopyranoside 6-O-(4-hydroxy-3,5-dimethoxybenzoate)

3-O-beta-D-[6-(4-hydroxy-3,5-dimethoxybenzoyl)]glucopyranosyl-gamma-pyranone|6-O-(4-hydroxy-3,5-dimethoxybenzoyl)-erigeroside|pyromeconic acid 3-O-beta-D-glucopyranoside 6-(O-4-hydroxy-3,5-dimethoxybenzoate)|pyromeconic acid 3-O-beta-D-glucopyranoside 6-O-(4-hydroxy-3,5-dimethoxybenzoate)

C20H22O12 (454.1111)


   
   

2,4-diacetoxy-1,3,7-trihydroxy-3-methyl-6,11-dioxo-1,2,3,4,6,11-hexahydro-benzo[b]carbazole-5-carbonitrile|Kinamycin D|Ninamycin D

2,4-diacetoxy-1,3,7-trihydroxy-3-methyl-6,11-dioxo-1,2,3,4,6,11-hexahydro-benzo[b]carbazole-5-carbonitrile|Kinamycin D|Ninamycin D

C22H18N2O9 (454.1012)


   

CAY10506

N-[2-[4-[(2,4-dioxo-5-thiazolidinyl)methyl]phenoxy]ethyl]-1,2-dithiolane-3-pentanamide

C20H26N2O4S3 (454.1055)


   

Phe-Phe4Cl-OH

(S)-2-(3-(benzyloxy)-4-nitrobenzamido)-3-(4-chlorophenyl)propanoic acid

C23H19ClN2O6 (454.0932)


   

Phe4Cl-Phe-OH

(S)-2-(3-((4-chlorobenzyl)oxy)-4-nitrobenzamido)-3-phenylpropanoic acid

C23H19ClN2O6 (454.0932)


   

5-Chloro-N-{(3s)-1-[(1s)-1-Methyl-2-Morpholin-4-Yl-2-5-Chloro-N-{(3s)-1-[(1s)-1-Methyl-2-Morpholin-4-Yl-2-Sulfonamide

5-Chloro-N-{(3s)-1-[(1s)-1-Methyl-2-Morpholin-4-Yl-2-5-Chloro-N-{(3s)-1-[(1s)-1-Methyl-2-Morpholin-4-Yl-2-Sulfonamide

C19H23ClN4O5S (454.1078)


   
   

4-{2,6,8-Trioxo-9-[(2S,3R,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-YL}butyl dihydrogen phosphate

4-{2,6,8-Trioxo-9-[(2S,3R,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-YL}butyl dihydrogen phosphate

C14H23N4O11P (454.1101)


   

4-{2,6,8-Trioxo-9-[(2R,3S,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-YL}butyl dihydrogen phosphate

4-{2,6,8-Trioxo-9-[(2R,3S,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-YL}butyl dihydrogen phosphate

C14H23N4O11P (454.1101)


   

Tivozanib

Tivozanib (AV-951)

C22H19ClN4O5 (454.1044)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EK - Vascular endothelial growth factor receptor (vegfr) tyrosine kinase inhibitors C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C93259 - VEGFR Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163953 - VEGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors

   

4-[4-[(5Z)-5-[(4-ethylphenyl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]butanoylamino]benzoic acid

4-[4-[(5Z)-5-[(4-ethylphenyl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]butanoylamino]benzoic acid

C23H22N2O4S2 (454.1021)


   

2-[[4-(3,4-dimethoxyphenyl)-6-(trifluoromethyl)-2-pyrimidinyl]thio]-N-(5-methyl-3-isoxazolyl)acetamide

2-[[4-(3,4-dimethoxyphenyl)-6-(trifluoromethyl)-2-pyrimidinyl]thio]-N-(5-methyl-3-isoxazolyl)acetamide

C19H17F3N4O4S (454.0923)


   

[(E)-4-[3-[2-(2,4-dihydroxyphenyl)-2-oxoethyl]-4,6-dihydroxy-2-methoxyphenyl]-2-methylbut-2-enyl] hydrogen sulate

[(E)-4-[3-[2-(2,4-dihydroxyphenyl)-2-oxoethyl]-4,6-dihydroxy-2-methoxyphenyl]-2-methylbut-2-enyl] hydrogen sulate

C20H22O10S (454.0934)


   

3,4,5-Trihydroxy-6-[[3-hydroxy-2-(2-hydroxypropan-2-yl)-7-oxo-2,3-dihydrouro[3,2-g]chromen-9-yl]oxy]oxane-2-carboxylic acid

3,4,5-Trihydroxy-6-[[3-hydroxy-2-(2-hydroxypropan-2-yl)-7-oxo-2,3-dihydrouro[3,2-g]chromen-9-yl]oxy]oxane-2-carboxylic acid

C20H22O12 (454.1111)


   

8,16-Dihydroxy-6-(6-hydroxy-1-benzouran-2-yl)-12-methyl-3,13-dioxapentacyclo[10.7.1.02,10.04,9.014,19]icosa-2(10),4,6,8,14(19),15,17-heptaen-11-one

8,16-Dihydroxy-6-(6-hydroxy-1-benzouran-2-yl)-12-methyl-3,13-dioxapentacyclo[10.7.1.02,10.04,9.014,19]icosa-2(10),4,6,8,14(19),15,17-heptaen-11-one

C27H18O7 (454.1052)


   

hydroxy-2-naphthalenyl-methyl phosphonic acid trisacetoxymethylester

hydroxy-2-naphthalenyl-methyl phosphonic acid trisacetoxymethylester

C20H23O10P (454.1029)


An organic phosphonate that is the trisacetoxymethylester derivative of naphthalene substituted hydroxymethylphosphonic acid. It has been found to inhibit insulin receptor tyrosine kinase activity and insulin stimulated glucose oxidation.

   

MK-3903

MK-3903

C27H19ClN2O3 (454.1084)


MK-3903 is a potent and selective AMP-activated protein kinase (AMPK) activator with an EC50 of 8 nM.

   

ML349

ML349

C23H22N2O4S2 (454.1021)


ML349 is a potent and specific acyl protein thioesterase 2(APT2)/lysophospholipase 2 (LYPLA2) inhibitor with a Ki of 120 nM. ML349 is also an inhibitor of LYPLA2 with an IC50 of 144 nM[1][2].

   

4-(acetyloxy)-5-cyano-1,3,7-trihydroxy-3-methyl-6,11-dioxo-1h,2h,4h-benzo[b]carbazol-2-yl acetate

4-(acetyloxy)-5-cyano-1,3,7-trihydroxy-3-methyl-6,11-dioxo-1h,2h,4h-benzo[b]carbazol-2-yl acetate

C22H18N2O9 (454.1012)


   

(4-oxo-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}pyran-2-yl)methyl 4-hydroxy-3-methoxybenzoate

(4-oxo-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}pyran-2-yl)methyl 4-hydroxy-3-methoxybenzoate

C20H22O12 (454.1111)


   

(4-oxo-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}pyran-2-yl)methyl 4-hydroxy-3-methoxybenzoate

(4-oxo-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}pyran-2-yl)methyl 4-hydroxy-3-methoxybenzoate

C20H22O12 (454.1111)


   

[6-(2,4-dihydroxy-6-methylphenoxy)-3,4,5-trihydroxyoxan-2-yl]methyl 3,4,5-trihydroxybenzoate

[6-(2,4-dihydroxy-6-methylphenoxy)-3,4,5-trihydroxyoxan-2-yl]methyl 3,4,5-trihydroxybenzoate

C20H22O12 (454.1111)


   

[3,4,5-trihydroxy-6-(4-hydroxy-2-methoxyphenoxy)oxan-2-yl]methyl 3,4,5-trihydroxybenzoate

[3,4,5-trihydroxy-6-(4-hydroxy-2-methoxyphenoxy)oxan-2-yl]methyl 3,4,5-trihydroxybenzoate

C20H22O12 (454.1111)


   

[3,4,5-trihydroxy-6-(3-hydroxy-5-methoxyphenoxy)oxan-2-yl]methyl 3,4,5-trihydroxybenzoate

[3,4,5-trihydroxy-6-(3-hydroxy-5-methoxyphenoxy)oxan-2-yl]methyl 3,4,5-trihydroxybenzoate

C20H22O12 (454.1111)


   

[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-(3-hydroxy-5-methoxyphenoxy)oxan-2-yl]methyl 3,4,5-trihydroxybenzoate

[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-(3-hydroxy-5-methoxyphenoxy)oxan-2-yl]methyl 3,4,5-trihydroxybenzoate

C20H22O12 (454.1111)


   

(1r,2r,3r,4s)-1-(acetyloxy)-2,4,9-trihydroxy-2-methyl-5,10-dioxo-11-(λ⁵-diazynylidene)-1h,3h,4h-benzo[b]fluoren-3-yl acetate

(1r,2r,3r,4s)-1-(acetyloxy)-2,4,9-trihydroxy-2-methyl-5,10-dioxo-11-(λ⁵-diazynylidene)-1h,3h,4h-benzo[b]fluoren-3-yl acetate

C22H18N2O9 (454.1012)


   

[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-(4-hydroxy-2-methoxyphenoxy)oxan-2-yl]methyl 3,4,5-trihydroxybenzoate

[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-(4-hydroxy-2-methoxyphenoxy)oxan-2-yl]methyl 3,4,5-trihydroxybenzoate

C20H22O12 (454.1111)


   

[(2r,3s,4s,5r,6s)-6-(2,4-dihydroxy-6-methylphenoxy)-3,4,5-trihydroxyoxan-2-yl]methyl 3,4,5-trihydroxybenzoate

[(2r,3s,4s,5r,6s)-6-(2,4-dihydroxy-6-methylphenoxy)-3,4,5-trihydroxyoxan-2-yl]methyl 3,4,5-trihydroxybenzoate

C20H22O12 (454.1111)


   

[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-(4-hydroxy-3-methoxyphenoxy)oxan-2-yl]methyl 3,4,5-trihydroxybenzoate

[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-(4-hydroxy-3-methoxyphenoxy)oxan-2-yl]methyl 3,4,5-trihydroxybenzoate

C20H22O12 (454.1111)


   

[3,4,5-trihydroxy-6-(4-hydroxy-3-methoxyphenoxy)oxan-2-yl]methyl 3,4,5-trihydroxybenzoate

[3,4,5-trihydroxy-6-(4-hydroxy-3-methoxyphenoxy)oxan-2-yl]methyl 3,4,5-trihydroxybenzoate

C20H22O12 (454.1111)


   

(1r,2r,3r,4s)-1,3-bis(acetyloxy)-11-(diazyn-1-ium-1-yl)-2,4,10-trihydroxy-2-methyl-5-oxo-1h,3h,4h-benzo[b]fluoren-9-olate

(1r,2r,3r,4s)-1,3-bis(acetyloxy)-11-(diazyn-1-ium-1-yl)-2,4,10-trihydroxy-2-methyl-5-oxo-1h,3h,4h-benzo[b]fluoren-9-olate

C22H18N2O9 (454.1012)